Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunovia
Hwaseong, Gyeonggi-do, South Koreayunovia.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Yunovia is a South Korean biotechnology company established in 2023 as a spin-off from Ildong Pharmaceutical's research and development division. The company is dedicated to developing a diverse pipeline of innovative therapies, with a primary focus on metabolic diseases, gastrointestinal disorders, and central nervous system conditions. Its lead clinical assets include a potassium-competitive acid blocker (P-CAB) for gastric acid-related diseases and an oral small molecule GLP-1 receptor agonist for obesity and type 2 diabetes. Yunovia also maintains active programs in non-alcoholic steatohepatitis (NASH) and Parkinson's disease. By operating as an independent entity, the company seeks to enhance R&D efficiency and facilitate global licensing deals and investment.
- Therapeutic areas
- NeurologyEndocrinologyGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Yunovia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yunovia.